Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 20; no. 3; pp. e41 - e42
Main Authors Wu, Peng, Li, Dongyu, Zhang, Chaoqi, Sun, Nan, He, Jie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2025
Online AccessGet full text
ISSN1556-0864
1556-1380
1556-1380
DOI10.1016/j.jtho.2024.11.017

Cover

Author Sun, Nan
He, Jie
Li, Dongyu
Zhang, Chaoqi
Wu, Peng
Author_xml – sequence: 1
  givenname: Peng
  surname: Wu
  fullname: Wu, Peng
  organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
– sequence: 2
  givenname: Dongyu
  surname: Li
  fullname: Li, Dongyu
  organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
– sequence: 3
  givenname: Chaoqi
  surname: Zhang
  fullname: Zhang, Chaoqi
  organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
– sequence: 4
  givenname: Nan
  surname: Sun
  fullname: Sun, Nan
  organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
– sequence: 5
  givenname: Jie
  surname: He
  fullname: He, Jie
  email: prof.jiehe@gmail.com
  organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40049767$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtLxDAUhYMovv-AC8nSzdQkTdqOCDIUXzCM4gOXIU1unZRpMyap4L-3w4y6c3UPN98JyTkHaLtzHSB0QklCCc3Om6SJc5cwwnhCaUJovoX2qRDZiKYF2d5oUmR8Dx2E0BDCBeHFLtrjgxznWb6P7KOKFroY8JuNc_wEAXRU1QLw7Lmclvi1M-Dfne3e8QycMk3_qbqIyzm0zrZt37k4B6-WXxf4xeHJz7nzeOYijn-rqyO0U6tFgOPNPESvN9cv5d1o-nB7X06mI83SPI40aKaEMGZcawFcZEQoRQjJWK01DI_WYmyqSnMOADURohbKmIKN07wqKmDpITpb37v07qOHEGVrg4bFQnXg-iBTmvOCUVqs0NMN2lctGLn0tlX-S_7EMwBsDWjvQvBQ_yKUyFUHspGrDuSqA0mpHDoYTJdrEwy__LTgZdBDxBqM9UO40jj7n_0bxiKQiQ
Cites_doi 10.1186/s12874-021-01308-8
10.1001/jamaoncol.2017.2797
10.1001/jamanetworkopen.2024.1285
10.1016/j.jtho.2024.09.1443
10.1001/jamaoncol.2022.5816
ContentType Journal Article
Copyright 2024 International Association for the Study of Lung Cancer
Copyright_xml – notice: 2024 International Association for the Study of Lung Cancer
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.jtho.2024.11.017
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1556-1380
EndPage e42
ExternalDocumentID 40049767
10_1016_j_jtho_2024_11_017
S1556086424024808
Genre Letter
Correspondence
GroupedDBID ---
.55
.XZ
.Z2
0R~
457
53G
5GY
5VS
AAEDW
AAKAS
AALRI
AAWTL
AAXUO
AAYWO
ABBUW
ABJNI
ABMAC
ABPMR
ACDDN
ACGFS
ACWDW
ACWRI
ADBBV
ADBIZ
ADEZE
ADVLN
ADZCM
AE3
AENEX
AEXQZ
AFETI
AFJKZ
AFTJW
AFTRI
AGCQF
AGHFR
AITUG
AIZYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BOYCO
C45
CS3
DU5
E.X
EBS
EJD
EX3
F5P
FDB
FL-
HZ~
IN~
KD2
NTWIH
O9-
OFXIZ
OGEVE
OK1
OVD
P2P
ROL
S4S
SSZ
TEORI
V2I
W3M
WOQ
WOW
X7M
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
AACTN
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c237t-cec2a55dd9fc5e45605aa00062fcce976c59dbbc44eeef055f5add82937b8be23
ISSN 1556-0864
1556-1380
IngestDate Fri Sep 05 12:01:18 EDT 2025
Sat Mar 08 01:23:54 EST 2025
Tue Jul 01 04:57:27 EDT 2025
Sat Jun 07 17:02:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c237t-cec2a55dd9fc5e45605aa00062fcce976c59dbbc44eeef055f5add82937b8be23
Notes content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
PMID 40049767
PQID 3174821182
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3174821182
pubmed_primary_40049767
crossref_primary_10_1016_j_jtho_2024_11_017
elsevier_sciencedirect_doi_10_1016_j_jtho_2024_11_017
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2025
2025-03-00
2025-Mar
20250301
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: March 2025
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of thoracic oncology
PublicationTitleAlternate J Thorac Oncol
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Liu, Zhou, Lee (bib3) 2021; 21
Marinelli, Nuccio, Di Federico (bib1) 2025; 20
Pak, Uno, Kim (bib5) 2017; 3
Yap, Leone, Wong (bib4) 2023; 9
Zhou, Li, Yu (bib2) 2024; 7
Liu (10.1016/j.jtho.2024.11.017_bib3) 2021; 21
Pak (10.1016/j.jtho.2024.11.017_bib5) 2017; 3
Zhou (10.1016/j.jtho.2024.11.017_bib2) 2024; 7
Marinelli (10.1016/j.jtho.2024.11.017_bib1) 2025; 20
Yap (10.1016/j.jtho.2024.11.017_bib4) 2023; 9
References_xml – volume: 9
  start-page: 215
  year: 2023
  end-page: 224
  ident: bib4
  article-title: Effectiveness of immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma: a meta-analysis including low pd-l1 subgroups
  publication-title: JAMA Oncol
– volume: 20
  start-page: 285
  year: 2025
  end-page: 295
  ident: bib1
  article-title: Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
  publication-title: J Thorac Oncol
– volume: 3
  start-page: 1692
  year: 2017
  end-page: 1696
  ident: bib5
  article-title: Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio
  publication-title: JAMA Oncol
– volume: 21
  start-page: 111
  year: 2021
  ident: bib3
  article-title: Ipdfromkm: reconstruct individual patient data from published Kaplan-Meier survival curves
  publication-title: BMC Med Res Methodol
– volume: 7
  year: 2024
  ident: bib2
  article-title: Neoadjuvant-adjuvant vs neoadjuvant-only pd-1 and pd-l1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis
  publication-title: JAMA Netw Open
– volume: 21
  start-page: 111
  year: 2021
  ident: 10.1016/j.jtho.2024.11.017_bib3
  article-title: Ipdfromkm: reconstruct individual patient data from published Kaplan-Meier survival curves
  publication-title: BMC Med Res Methodol
  doi: 10.1186/s12874-021-01308-8
– volume: 3
  start-page: 1692
  year: 2017
  ident: 10.1016/j.jtho.2024.11.017_bib5
  article-title: Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2017.2797
– volume: 7
  year: 2024
  ident: 10.1016/j.jtho.2024.11.017_bib2
  article-title: Neoadjuvant-adjuvant vs neoadjuvant-only pd-1 and pd-l1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2024.1285
– volume: 20
  start-page: 285
  year: 2025
  ident: 10.1016/j.jtho.2024.11.017_bib1
  article-title: Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2024.09.1443
– volume: 9
  start-page: 215
  year: 2023
  ident: 10.1016/j.jtho.2024.11.017_bib4
  article-title: Effectiveness of immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma: a meta-analysis including low pd-l1 subgroups
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2022.5816
SSID ssj0045048
Score 2.4405544
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage e41
Title Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
URI https://dx.doi.org/10.1016/j.jtho.2024.11.017
https://www.ncbi.nlm.nih.gov/pubmed/40049767
https://www.proquest.com/docview/3174821182
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgk6a9IL5XvmQk3qJUqWM3KS-oqkATgwpBJ_YW2Y69thLxKMkD_HquY7sJK0XAS1Q5bdr4nF4f2-feIPRCMw4Dlx7HWo9YTPlkFAs9GsU6U4SWqchS3bot5uPTc_r2gl10O7ptdkkthvLHb_NK_gdVaANcbZbsPyC7vSg0wGvAF46AMBz_CuMPriiq9bDWy9ZEJ-s2FWr-afZuFrXPNLo0djFgrgwv1w3I5jqyNQLMyuaF-OyrtujTwkTT8A6zieamtrI0NF3z__VkbL0EEsmVjEwlf12ib5z_1w-N1vTjktpNdfm92Vmwni25-brq9qgqH_v7yxKEdb6sofKh1FU4TPqxliQ9TqW9wKlc-audgO7WFtZwe0ubqkno0NZcdemePYSvvrQQ24AE-irrBret5TCcuokOSZbZHf3D6dnHz2dh2KYMYpnPqnIGwOtfeYyOwkX2iZh9k5RWrCxuo1seHjx1lLmDbqjqLjp6730U99AqMAdb5uCOObhlDu6Yg3vMwbvMeYkXBgeSYLPBwBtcd02v7qPzN68Xs9PYP3QjliTN6lgqSThjZTnRkimQ1wnj3IoaoqVUcPOSTUohJKVKKZ0wBv_2ssxBNWYiF4qkD9BBZSp1gnCuJiNOcp1DPLBaSZSUCZWMhVClpDwdoCj0YnHlaqsUwXS4Lmz3F7b7YZJaQPcPEAsdXXh16FRfAVz54-eeB1QKCJ12P4xXyjTfCpDONCd2hj1ADx1c298RkH6098xjdNzx_gk6qDeNegoCtRbPPLV-AtKOkpY
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patients+With+Resectable+NSCLC+Undergoing+Neoadjuvant+Chemoimmunotherapy%3A+To+Adjuvant+or+Not+to+Adjuvant%3F&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Wu%2C+Peng&rft.au=Li%2C+Dongyu&rft.au=Zhang%2C+Chaoqi&rft.au=Sun%2C+Nan&rft.date=2025-03-01&rft.eissn=1556-1380&rft.volume=20&rft.issue=3&rft.spage=e41&rft_id=info:doi/10.1016%2Fj.jtho.2024.11.017&rft_id=info%3Apmid%2F40049767&rft.externalDocID=40049767
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon